ProtaGene

ProtaGene is a bioanalytical contract research organisation serving biopharma clients from pre-IND development through to commercial release. Its work concentrates on two areas: protein analytics and analytical support for gene therapy programmes. Services span molecule-specific assay development, analytical method development and the regulatory support required to move candidates through FDA and EMA pathways.

The company operates from four sites across Europe and North America. Its technical domains include protein analytics, gene therapy analytics, and the quality systems and data-integrity practices that underpin regulated bioanalysis. Assays are developed specifically for a client's molecule rather than drawn from a fixed catalogue.

ProtaGene describes its working model as one of scientific ownership and collaborative partnership with clients. It cites flat hierarchies, short decision-making paths and transparent communication, with an emphasis on realistic commitments and direct problem-solving within a quality-system-driven environment. The firm states that it values the exchange of ideas as much as results.